Association of estrogen metabolism with breast cancer risk in different cohorts of postmenopausal women

Cancer Research

Volumn 77, Issue 4, 2017, Pages 918-925

  Sampson, Joshua N ^a   Falk, Roni T ^a   Schairer, Catherine ^a   Moore, Steven C ^a   Fuhrman, Barbara J ^b   Dallal, Cher M ^c   Bauer, Douglas C ^d   Dorgan, Joanne F ^e   Shu, Xiao Ou ^f   Zheng, Wei ^f   Brinton, Louise A ^a   Gail, Mitchell H ^a   Ziegler, Regina G ^a   Xu, Xia ^g   Hoover, Robert N ^a   Gierach, Gretchen L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f VANDERBILT INGRAM CANCER CENTER   (United States)

^g FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16 EPIESTRIOL; 16 KETOESTRADIOL; 16ALPHA HYDROXYESTRONE; 17 EPIESTRIOL; 2 HYDROXYESTRADIOL; 2 HYDROXYESTRONE; 2 METHOXYESTRADIOL; 2 METHOXYESTRONE; 2 METHOXYESTRONE 3 METHYL ETHER; 4 HYDROXYESTRONE; 4 METHOXYESTRADIOL; 4 METHOXYESTRONE; ESTRADIOL; ESTRADIOL DERIVATIVE; ESTRIOL; ESTRONE; ESTRONE DERIVATIVE; UNCLASSIFIED DRUG; ESTROGEN;

ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; ESTROGEN BLOOD LEVEL; ESTROGEN METABOLISM; ESTRONE BLOOD LEVEL; HUMAN; HYDROXYLATION; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; METABOLITE; POSTMENOPAUSE; RISK REDUCTION; URINE LEVEL; VALIDATION STUDY; ADULT; AGED; BREAST NEOPLASMS; FEMALE; LIQUID CHROMATOGRAPHY; METABOLISM; MIDDLE AGED; RISK; TANDEM MASS SPECTROMETRY;

ADULT; AGED; BREAST NEOPLASMS; CHROMATOGRAPHY, LIQUID; COHORT STUDIES; ESTROGENS; FEMALE; HUMANS; HYDROXYLATION; MIDDLE AGED; POSTMENOPAUSE; RISK; TANDEM MASS SPECTROMETRY;

EID: 85014030269     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-16-1717     Document Type: Article

References (27)

1. Feigelson HS, Henderson BE. Estrogens and breast cancer. Carcinogenesis 1996;17:2279-84.
2. Yager JD. Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 2000;27:67-73.
3. Key T, Appleby P, Barnes I, Reeves G; Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
4. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354:270-82.
5. Yue W, Yager JD, Wang JP, Jupe ER, Santen RJ. Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis. Steroids 2013;78:161-70.
6. Swaneck GE, Fishman J. Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc Natl Acad Sci U S A 1988;85:7831-5.
7. Seeger H, Wallwiener D, Kraemer E, Mueck AO. Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells. Maturitas 2006;54:72-7.
8. Santen RJ, Yue W, Wang JP. Estrogen metabolites and breast cancer. Steroids 2015;99:61-6.
9. Ziegler RG, Fuhrman BJ, Moore SC, Matthews CE. Epidemiologic studies of estrogen metabolism and breast cancer. Steroids 2015;99(Pt A):67-75.
10. Fuhrman BJ, Xu X, Falk RT, Dallal CM, Veenstra TD, Keefer LK, et al. Assay reproducibility and interindividual variation for 15 serum estrogens and estrogen metabolites measured by liquid chromatography-tandem mass spectrometry. Cancer Epidemiol Biomarkers Prev 2014;23:2649-57.
11. Falk RT, Xu X, Keefer L, Veenstra TD, Ziegler RG. A liquid chromatographymass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability. Cancer Epidemiol Biomarkers Prev 2008;17:3411-8.
12. Fuhrman BJ, Schairer C, Gail MH, Boyd-Morin J, Xu X, Sue LY, et al. Estrogen metabolism and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2012;104:326-39.
13. Falk RT, Brinton LA, Dorgan JF, Fuhrman BJ, Veenstra TD, Xu X, et al. Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study. Breast Cancer Res 2013;15:R34.
14. Dallal CM, Tice JA, Buist DS, Bauer DC, Lacey JV Jr, Cauley JA, et al. Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B-FIT. Carcinogenesis 2014;35:346-55.
15. Moore SC, Matthews CE, Ou Shu X, Yu K, Gail MH, Xu X, et al. Endogenous estrogens, estrogen metabolites, and breast cancer risk in postmenopausal Chinese women. J Natl Cancer Inst 2016;108:djw103.
16. Xu X, Veenstra TD, Fox SD, Roman JM, Issaq HJ, Falk R, et al. Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal Chem 2005;77:6646-54.
17. Xu X, Roman JM, Issaq HJ, Keefer LK, Veenstra TD, Ziegler RG. Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry. Anal Chem 2007;79:7813-21.
18. R-Core-Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2015.
19. Schairer C, Fuhrman BJ, Boyd-Morin J, Genkinger JM, Gail MH, Hoover RN, et al. Quantifying the role of circulating unconjugated estradiol in mediating the body mass index-breast cancer association. Cancer Epidemiol Biomarkers Prev 2016;25:105-13.
20. Matthews CE, Fortner RT, Xu X, Hankinson SE, Eliassen AH, Ziegler RG. Association between physical activity and urinary estrogens and estrogen metabolites in premenopausal women. J Clin Endocrinol Metab 2012;97:3724-33.
21. Dallal CM, Brinton LA, Matthews CE, Pfeiffer RM, Hartman TJ, Lissowska J, et al. Association of active and sedentary behaviors with postmenopausal estrogen metabolism. Med Sci Sports Exerc 2016;48:439-48.
22. Falk RT, Fears TR, Xu X, Hoover RN, Pike MC, Wu AH, et al. Urinary estrogen metabolites and their ratio among Asian American women. Cancer Epidemiol Biomarkers Prev 2005;14:221-6.
23. Thomas HV, Reeves GK, Key TJ. Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes Control 1997;8:922-8.
24. Zhang X, Tworoger SS, Eliassen AH, Hankinson SE. Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res Treat 2013;137:883-92.
25. James RE, Lukanova A, Dossus L, Becker S, Rinaldi S, Tjønneland A, et al. Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study. Cancer Prev Res 2011;4:1626-35.
26. Farhat GN, Cummings SR, Chlebowski RT, Parimi N, Cauley JA, Rohan TE, et al. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers. J Natl Cancer Inst 2011;103:562-70.
27. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (SEER 18 Registries for 2000-2012), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch.